Analysis of the peripheral blood t-cell receptor (tcr) repertoire in monozygotic twins discordant for crohn's disease

References

• Selby WS, Janossy G, Bofill M, Jewell DP. Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut 1984; 25: 32–40
   PubMed Web of Science ®Google Scholar
• Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertov-Ich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991; 101: 1020–30
   PubMed Web of Science ®Google Scholar
• Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987; 28: 745–53
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Bergroth V, Nordstrom D, Segerberg-Konttinen M, Seppä#ä K, Salaspuro M. Lymphocyte activation in vivo in the intestinal mucosa of patients with Crohn's disease. J Clin Lab Immunol 1987; 22: 59–63
   PubMedGoogle Scholar
• Choy MY, Walker-Smith JA, Williams CB, MacDonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 1990; 31: 1365–70
   PubMed Web of Science ®Google Scholar
• Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992; 102: 1620–7
   PubMed Web of Science ®Google Scholar
• Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin 2 and interferon-gamma secreting T cells in normal and diseased intestinal mucosa. Immunology 1993; 78: 127–131
   PubMed Web of Science ®Google Scholar
• Allison MC, Pounder RE. Cyclosporin for Crohn's disease. Lancet 1984; 1: 902–3
   PubMed Web of Science ®Google Scholar
• Brunskov J. The role of cyclosporin therapy in Crohn's disease. Dig Dis 1991; 9: 236–44
   PubMedGoogle Scholar
• Brynskov J, Freund L, Rasmussen SN. A placebo-controlled double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321: 845–50
   PubMed Web of Science ®Google Scholar
• Hodgson HJF. Cyclosporin in inflammatory bowel disease. Aliment Pharmacol Therap 1991; 5: 343–50
   PubMedGoogle Scholar
• Present DH, Korelitz Bl., Wisch N., Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine: A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981–7
   PubMed Web of Science ®Google Scholar
• Rosenberg JL, Levin B, Wall AJ. A controlled trial of azathioprine in Crohn's disease. Dig Dis Sci 1975; 20: 721–6
   Google Scholar
• Willoughby CP, Kumar PJ, Beckett J. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944–7
   PubMed Web of Science ®Google Scholar
• Raedler A, Fraenkel S, Klose G, Seyfarth K, Thiele HG. Involvement of the immune system in the pathogenesis of Crohn's disease. Gastroenterology 1985; 88: 978–83
   PubMed Web of Science ®Google Scholar
• Brynskov J, Tvede N. Plasma interleukin-2 and soluble/ shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut 1990; 31: 795–9
   PubMed Web of Science ®Google Scholar
• Mueller C, Knoflach P, Zielinski CC. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990; 9: 639–46
   Google Scholar
• Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin 2 and interferon-gamma secreting T cells in normal and diseased intestinal muscosa. Immunology 1993; 78: 127–131
   PubMed Web of Science ®Google Scholar
• Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. Tcell antigen receptor V gene usage. Increases in Vβ8 + T cells in Crohn's disease. J Clin Invest 1990; 85: 1770–6
   PubMed Web of Science ®Google Scholar
• Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin “su-perantigens” with human T cells. Proc Natl Acad Sci 1989; 86: 8941–45
   PubMed Web of Science ®Google Scholar
• Drake CG, Kotzin BL. Superantigens: biology, immunology and potential role in disease. J Clin Immunol 1992; 12: 149–62
   PubMed Web of Science ®Google Scholar
• Gulwani-Akolkar B, Posnett DN, Janson CH, Grunewald J, Wigzell H, Akolkar P, Gregersen PK, Silver J. T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med 1991; 174: 1139–46
   PubMed Web of Science ®Google Scholar
• Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, Bigler RD, Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 1993; 150: 2761–2773
   PubMed Web of Science ®Google Scholar
• Kirsner JB, Shorter RG. Recent developments in “nonspecific” inflammatory bowel disease. N Engl J Med 1982; 306: 37–848
   Google Scholar
• Lockhart-Mummery HE, Morson BC. Crohn's disease (regional enterities) of the large intestine and its distiction from ulcerative colitis. Gut 1960; 87–105
   PubMedGoogle Scholar
• Bigler RD, Posnett DN, Chiorazzi N. Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor. J. Exp. Med. 1985; 161: 1450–1463
   PubMed Web of Science ®Google Scholar
• Wang CY, Bushkin Y, Pica R, Lane C, McGrath H, Posnett DN. Stimulation and expansion of a human T cell subpop-ulation by a monoclonal antibody to T cell receptor molecule. Hybridoma 1986; 5: 179–189
   PubMedGoogle Scholar
• Posnett DN, Wang CY, Friedman S. Inherited polymorphism of the human T cell antigen receptor detected by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 1986; 83: 7888–7892
   PubMed Web of Science ®Google Scholar
• Acuto O, Campen TJ, Royer HD, Hussey RE, Poole CB, Reinherz EL. Molecular analysis of T cell receptor (Ti) variable region (V) gene expression. Evidence that a single Ti p V gene family can be used in formation of V domains o phenotypically and functionally diverse T cell populations. J. Exp. Med. 1985; 161: 1326–1343
   PubMedGoogle Scholar
• Maecker HT, Levy R. Prevalence of antigen receptor variants in human T cell lines and tumors. J. Immunol. 1989; 142: 395–1404
   Google Scholar
• Tian WT, Skibbens R, Kubincc J, Henry L, Ko J-L, Yeh G, Lp S. Monoclonal antibodies specific to human T cell antigen receptor Vp gene products. FASEB J. 1989; 3: A486
   Google Scholar
• Friedman SM, Crow MK, Tumang JR, Tumang M., Xu Y, Hodtsev AS, Cole BC, Posnett DN. Characterization of human T cells reactive with the mycoplasma arthritides-derived superantigen (MAM): generation of a monoclonal antibody against Vpi7, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells. J. Exp. Med. 1991; 174: 891–900
   PubMed Web of Science ®Google Scholar
• Janson CH, Tehrani MJ, Mellstedt H, Wigzell H. Antiidiotype monclonal antibody to a T cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy. Cancer Immunol. & Immunotherapy 1989; 28: 225–232
   PubMedGoogle Scholar
• DerSimonian H, Band H, Brenner MB. Increased frequency of Tcell receptor Val2.1 expression on CD8 + T cells: evidence that Va participates in shaping the peripheral Tcell repertoire. J. Exp. Med. 1991; 174: 639–648
   PubMedGoogle Scholar
• Devaux B, Bjorkman PJ, Stevenson C, Greif W, Elliott JF, Sagerstrom C, Clayberger C, Krensky AM, Davis MM. Generations of monoclonal antibodies against soluble human Tcell receptor polypeptides. Eur. J. Immunol 1991; 2111–2119
   PubMedGoogle Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical biochemistry 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Marrack P, Kappler J. The staphylococcal entreotoxins and their relatives. Science 1990; 248: 705–11
   PubMed Web of Science ®Google Scholar
• Abe J, Kotzin B, Injo K, Melish ME, Glade MP, Kohasaka T, Lehng DYM. Selective expansion of T cells expressing T cell receptor variable regions Vp2 and Vp8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA 1992; 89: 4066–4070
   PubMed Web of Science ®Google Scholar
• Abe J, Kotzin BL, Meisser C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DYM. Characterization of T cell repertoire changes in acute Kawasaki Disease./. Exp. Med. 1993; 177: 791–796
   PubMed Web of Science ®Google Scholar
• Paliard X, West SG. Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL. Evidence for the effects of a super-antigen in rheumatoid arthritis. Science 1991; 253: 325–329
   PubMed Web of Science ®Google Scholar
• Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, Carlo DJ, Brostoff SW. Limited T cell receptor p chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthirits. Proc. Natl. Acad. Sci. USA 1991; 88: 109221–10925
   Google Scholar
• Mulhotra U, Spielman R, Concannon P. Variability in T cell receptor Vp gene usage in human peripheral blood lymphocytes. Studies of identical twins, siblings, and insulin dependent Diabetes MelJitus patients. J. Immunol 1992; 1802–1808
   PubMedGoogle Scholar
• Utz U, Biddison WE, McFarland HF, McFarlin DE, Fl-Erlagc M, Martin R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 1993; 364: 243–247
   PubMed Web of Science ®Google Scholar
• Shalon L, Gulwani-Akolkar B, Fisher SE, Akolkar P, Panja A, Mayer L, Silver J. An altered T-cell receptor repertoire in Crohn's disease, submitted.
   Google Scholar
• Toyoda H, Wang S-J, Yan H-Y, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR, Totter Jl. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741–748
   PubMed Web of Science ®Google Scholar